Latest in News & Research
Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
Two replicate double-blind, randomized, placebo-controlled trials show short-term efficacy for upadacitinib in adolescents and adults
More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy
Calcineurin Inhibitors, Phototherapy Do Not Increase Risk for Certain Cancers
No increased risk seen for lymphoma, skin cancer with topical calcineurin inhibitor, phototherapy use for vitiligo
Teledermatology Has Good Concordance for Diagnosis, Management
Agreement was almost perfect for imaging decisions and for treatment, but no agreement seen for follow-up planning
Internet-Delivered CBT Reduces Atopic Dermatitis Symptoms
Significant reductions also seen in itch intensity, perceived stress, sleep problems, and depression
Rituximab, Mycophenolate Mofetil Compared for Pemphigus Vulgaris
More patients receiving rituximab versus mycophenolate mofetil had sustained complete remission at week 52, fewer had disease flares
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
Time, Costs of Participation in MIPS Are Considerable
Mean cost to practices per physician $12,811; 201.7 hours annually spent per physician on MIPS-related activities
Baricitinib Shows Long-Term Efficacy for Atopic Dermatitis
Long-term sustained outcomes seen among adults with moderate-to-severe atopic dermatitis
Fully Vaccinated Can Shed Masks in Most Outdoor, Indoor Settings: CDC
Fully vaccinated Americans can now skip face masks and social distancing in most indoor or outdoor settings, the U.S. Centers for Disease Control and...
Many Current Topical Impetigo Treatments Have Developed Antibiotic Resistance
Topical ozenoxacin may effectively treat impetigo while meeting antibiotic stewardship principles
No Increased Risk Found for Soft Tissue Filler Reactions After COVID-19 Vaccine
Delayed inflammatory reactions in soft tissue fillers after COVID-19 vaccine similar to other triggers
Hand Dermatitis Currently Prevalent in Health Care Workers
Prevalence of hand dermatitis 92.6 percent in health care workers, 68.7 percent for general population
Delayed Hypersensitivity Reaction to Moderna COVID-19 Vaccine ID'd
Reaction occurred at or near injection site; reactions were pruritic, painful, and edematous pink plaques
Sunburns Severe Enough to Warrant Admission Described
Most patients sustained superficial burns and only 4 percent had full-thickness burns; 19 percent underwent burn wound management surgery
FDA Approves Emergency Use of Pfizer Vaccine for Those Aged 12 to 15
By Physician’s Briefing Staff
Clinical Size of Lentigo Maligna Melanoma Does Not Predict Invasion
However, larger lesions require wider surgical margins
Impact of Hidradenitis Suppurativa on Work Productivity Examined
Inguinal/gluteal involvement, severe disease, and higher depression and anxiety scores more common among nonworkers
Topical Corticosteroid Use in Pregnancy Not Tied to SGA, LBW
Risks for small for gestational age or low birth weight not increased with exposure to potent or very potent topical corticosteroids
Early-Life Exposure to Antibiotics Linked to Atopic Dermatitis
Exposure in utero and during first year of life linked to increased risk for atopic dermatitis; attenuated in sibling-control analysis
Many Americans Wrong About Sun's Skin Cancer Dangers: Poll
Survey results show Generation Z and millennials have the greatest misunderstandings about sun exposure
Dupilumab Tied to Facial, Neck Erythema
Several patients with baseline atopic dermatitis reported symptoms differing from their usual symptoms
Most Patients Satisfied With Glabellar Botulinum Toxin Retreatments Every Six Months
Vast majority of patients satisfied with six-month retreatment for glabellar lines utilizing AbobotulinumtoxinA
24 of 1292